3412 results for «2022»
3412 results
Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty
18 May 2022
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
MedAlliance Acquires Japanese Partner MDK Medical
02 Feb 2022
EDIT-CMD trial results: edifying our approach to patients with ANOCA
03 Apr 2022
Dejan Milasinovic provides his take on the EDIT-CMD Randomized Clinical Trial which aimed to assess the efficacy of diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries.
Author
No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial
04 Apr 2022
Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.
Author
Bentley acquired the GoBack catheter
13 Sep 2022
Vesalio announces FDA Approval of the NeVa VS™ to treat cerebral vasospasm after aneurysmal rupture
15 Sep 2022
First Patient Enrolled in SELUTION SLR IDE BTK Study
08 Jun 2022
Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent
21 Jul 2022
Vesalio appoints VP of U.S. Sales and announces recent publication on NeVa showing impressive first pass rates
29 Nov 2022
Recruitment complete in BEVAR study for on-label use of the Bentley BeGraft peripheral PLUS as a bridging stent
10 Mar 2023
First Patient enrolled in the clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft
09 Feb 2024
Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out
14 Nov 2023
Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.
Author
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study
22 Aug 2022
TAVI session from PCR London Valves 2025 : Abbott
26 Nov 2025
Watch these recordings from PCR London Valves 2025 on TAVI.
FDA approves US oriented clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft for treatment of aortic aneurysms CAUTION: Investigational device. Limited by United States law to investigational use.
28 Jun 2023
MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SELUTION4SFA
04 May 2023
A short history of the Euro4C Group
16 Jan 2019
Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
Double barrel in CTO PCI
23 Apr 2024
This EIJ image illustrates a crucial case, emphasizing the importance of confirming wire position in the true lumen during dissection and re-entry techniques in CTO PCI.
